Acute motor and sensory axonal neuropathy (AMSAN) in a 15-year-old boy presenting with severe pain and distal muscle weakness

Neuropediatrics

Volumn 36, Issue 4, 2005, Pages 260-264

  Rostásy, Kevin M ^a   Huppke, P ^a   Beckers, B ^a   Brockmann, K ^a   Degenhardt, V ^b   Wesche, B ^b   Konig F ^a   Gartner J ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Städtisches Krankenhaus Hildesheim   (Germany)

Author keywords

AMSAN; Children; IVIG; Pain management

Indexed keywords

ANTIDEPRESSANT AGENT; DIPYRONE; GABAPENTIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MORPHINE; PIRITRAMIDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ACTION POTENTIAL; ACUTE MOTOR AND SENSORY AXONAL NEUROPATHY; ADOLESCENT; ARTICLE; CASE REPORT; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUSCLE CONTRACTION; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROPATHY; PAIN; PRIORITY JOURNAL; SENSORY NERVE; SLEEP PATTERN; SUICIDAL BEHAVIOR; TENDON REFLEX; WEIGHT REDUCTION;

ADOLESCENT; ANTIGENS, CD8; AXONS; ELECTROPHYSIOLOGY; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE WEAKNESS; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; PAIN; RECEPTORS, VIRUS; SURAL NERVE;

EID: 24744472033     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-865774     Document Type: Article

References (15)

1. Alam TA, Chaudhry V, Cornblath DR. Electrophysiological studies in the Guillain-Barré syndrome: Distinguishing subtypes by published criteria. Muscle Nerve 1998; 21: 1275-1279
2. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280: 1831-1836
3. Chowdhury D, Arora A. Axonal Guillain-Barré syndrome: a critical review. Acta Neurol Scand 2001; 103: 267-277
4. Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P et al. Pathology of motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996; 39: 17-28
5. Hahn K, Arendt G, Braun JS, von Giesen HJ, Husstedt IW, Maschke M et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 2004; 251: 1260-1266
6. Ho TW, Hsieh ST, Nachamkin I, Willison HJ, Sheikh K, Kiehlbauch J et al. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 1997; 48: 717-724
7. Khatri A, Pearlstein L. Pain in Guillain-Barré syndrome. Neurology 1997; 49: 1474
8. Korinthenberg R, Monting JS. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study. Arch Dis Child 1996; 74: 281-287
9. Massaro ME, Rodriguez EC, Pociecha J, Arroyo HA, Sacolitti M, Taratuto AL et al. Nerve biopsy in children with severe Guillain-Barré syndrome and inexcitable motor nerves. Neurology 1998; 51: 394-398
10. Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl J Med 2003; 348: 1243-1255
11. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997; 349: 225-230
12. Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990; 42: 135-144
13. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000; 55: 915-920
14. Sladky JT. Guillain-Barré syndrome. In: Jones HR, de Vivo DC, Darras BT (eds). Neuromuscular Disorders of Infancy, Childhood, and Adolescents. Philadelphia: Butterworth, Heinemann, 2003: 407-424
15. Yuki N, Kuwabara S, Koga M, Hirata K. Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile. J Neurol Sci 1999; 168: 121-126